Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q2 2026 (June 30)3holders −2
1new positions
3sold out
$0.91avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were Bank of New York Mellon Corp ($272K), Financial Sense Advisors, Inc. ($201K) and Crestwood Advisors Group, LLC ($32K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32K |
| Exits | 3 | $457K |
All 13F filers, Q1 2026 → Q2 2026: 35,000 shares bought and 506,000 shares sold, net −471,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $272K |
| Financial Sense Advisors, Inc. | 0.04% | No change | 220,000 | $201K |
| Crestwood Advisors Group, LLC | 0.00% | New | 35,000 | $32K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.